Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Ibuprofen Lysinate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 40Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Exela Issues Voluntary Recall of Ibuprofen Lysine Injection
    Exela Issues Voluntary Recall of Ibuprofen Lysine Injection

    08 Feb 2017

    // FDA

    http://www.fda.gov/Safety/Recalls/ucm540769.htm

    FDA
    08 Feb 2017
    Share Share
    Nurofen Maker Hit by $6M Fine Over
    Nurofen Maker Hit by $6M Fine Over

    17 Dec 2016

    // PHARMA FILE

    http://www.pharmafile.com/news/511967/nurofen-maker-hit-6m-fine-over-misleading-conduct

    PHARMA FILE
    17 Dec 2016
    Share Share
    Reckitt Benckiser hit with double dose of problems in Korea, Australia
    Reckitt Benckiser hit with double dose of problems in Korea, Australia

    03 May 2016

    // Ben Adams FIERCE ASIA

    http://www.fiercepharma.com/pharma-asia/reckitt-benckiser-hit-double-dose-problems-korea-australia

    Ben Adams FIERCE ASIA
    03 May 2016
    Share Share
    Exela Pharma’s Generic Ibuprofen Lysine approved in US a NSAID
    Exela Pharma’s Generic Ibuprofen Lysine approved in US a NSAID

    30 Mar 2016

    // FDA

    https://www.pharmacompass.com/pdf/news/exela-pharmas-generic-ibuprofen-lysine-approved-in-us-a-nsaid-1459595813.pdf

    FDA
    30 Mar 2016
    Share Share